Processa Pharmaceuticals Inc’s filing revealed that its Director Yorke Justin W acquired Company’s shares for reported $9889.0 on Jan 27 ’25. In the deal valued at $0.80 per share,12,400 shares were bought. As a result of this transaction, Yorke Justin W now holds 12,400 shares worth roughly $3595.9999999999995.
Then, Ng George K bought 87,200 shares, generating $69,542 in total proceeds. Upon buying the shares at $0.80, the Chief Executive Officer now owns 87,200 shares.
Before that, Young David bought 124,500 shares. Processa Pharmaceuticals Inc shares valued at $99,289 were divested by the Pres. Research & Development at a price of $0.80 per share. As a result of the transaction, Young David now holds 205,405 shares, worth roughly $59567.45.
H.C. Wainwright initiated its Processa Pharmaceuticals Inc [PCSA] rating to a Buy in a research note published on April 25, 2024; the price target was $8.
Price Performance Review of PCSA
On Monday, Processa Pharmaceuticals Inc [NASDAQ:PCSA] saw its stock fall -13.53% to $0.29. Over the last five days, the stock has lost -20.54%. Processa Pharmaceuticals Inc shares have fallen nearly -66.73% since the year began. Nevertheless, the stocks have fallen -87.33% over the past one year. While a 52-week high of $3.31 was reached on 01/06/25, a 52-week low of $0.24 was recorded on 04/02/25. SMA at 50 days reached $0.5057, while 200 days put it at $1.1223.
Levels Of Support And Resistance For PCSA Stock
The 24-hour chart illustrates a support level at 0.2618, which if violated will result in even more drops to 0.2296. On the upside, there is a resistance level at 0.3331. A further resistance level may holdings at 0.3722. The Relative Strength Index (RSI) on the 14-day chart is 28.75, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0643, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.21%. Stochastics %K at 30.47% indicates the stock is a holding.
How much short interest is there in Processa Pharmaceuticals Inc?
A steep rise in short interest was recorded in Processa Pharmaceuticals Inc stocks on 2025-03-14, dropping by -0.14 million shares to a total of 95265.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 0.24 million shares. There was a decline of -147.88%, which implies that there is a negative sentiment for the stock.
